Insulin Glulisine

BreastfeedingPediatric
  • TRADE NAME: Apidra (Sanofi-Aventis)
  • INDICATIONS: Diabetes
  • CLASS: Insulin analog
  • HALF-LIFE: 13–42 minutes
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

ACE inhibitors, Albuterol, Alcohol, Anitpsychotics, Beta blockers, Clonidine, Clozapine, Corticosteroids, Danazol, Disopyramide, Diuretics, Epinephrine, Fibrates, Fluoxetine, Glucagon, Guanethidine, Isoniazid, Lithium, MAO inhibitors, Niacin, Oral antidiabetic agents, Oral Contraceptives, Pentamidine, Pentoxifylline, Phenothiazine derivatives, Pramlintide, Propoxyphene, Propranolol, Protease inhibitors, Reserpine, Salicylates, Somatostatin analogs, Somatropin, Sulfonamide antibiotics, Terbutaline, Thyroid hormones

PREGNANCY CATEGORY: C

NOTE

Various forms of insulin are available - see other insulin profiles for reaction details.

Our database has 17 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.


Page last updated 08/01/2022

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top